| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $20K | +4.1% |
| SG&A Expense | $87K | +27.5% |
| Operating Income | -$1.2M | -19.1% |
| Interest Expense | $1.7M | +13.8% |
| Pre-tax Income | -$745 | +18.4% |
| Net Income | -$3.4M | -26.5% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $72K | — |
| Inventory | $421K | +134.4% |
| Current Assets | $838K | +366.3% |
| Total Assets | $1.1M | +141.5% |
| Current Liabilities | $8.2M | +13.7% |
| Long-term Debt | $4.1M | +27.4% |
| Total Liabilities | $8.2M | +13.5% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.6M | -220.0% |
| Investing Cash Flow | -$28K | -34.4% |
| Financing Cash Flow | $1.7M | +235.9% |
| Stockholders' Equity |
| -$7.1M |
| -4.6% |